Attention-deficit hyperactivity disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type
Conditions
Interventions
Intervention 1: Control group: The first group, they will receive the standard drug methylphenidate (Ritalin) with the dose of 1 mg / kg / day, In the first week (1.2 in the morning, 1.2 in the aftern
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 14 Years
Inclusion criteria
Inclusion criteria: Children 6 to 14 years old suspected to ADHD Obtain informed consent from the child's parent or guardian Diagnosis of ADHD by a psychiatrist New diagnosis of the disorder and not taking another drug
Exclusion criteria
Exclusion criteria: Mental retardation IQ <70 Simultaneous use of other methods of alternative and complementary medicine Having medical conditions including cardiovascular disease, gastrointestinal diseases, epilepsy Having other mental disorders including schizophrenia Existence of an organic brain problem Malnutrition and obvious growth disorders Recent treatment with antipsychotic drugs Drug dependence or abuse in the last 6 months History of allergies to sweet almonds and its products History of allergies to figs and its products Simultaneous consumption of other products containing almonds (nuts, almond sweets) and figs The need for behavioral therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of attention deficit / hyperactivity disorder based on the questionnaire score. Timepoint: At the beginning of the study (before the intervention), 4, 8 and 12 weeks after starting the drug. Method of measurement: Teacher and Parent ADHD rating scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of drug side effects. Timepoint: Once every 2 weeks after starting treatment. Method of measurement: Checklist of drug side effects and possible side effects based on CTCAE criteria (Common Terminology Criteria for Adverse Events v4.03, 2010).;BMI, and clinical examination results. Timepoint: 4, 8 and 12 weeks after the start of the intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Mahjoub
Iran University of Medical Sciences
Outcome results
None listed